Cargando…
BLyS/APRIL dual inhibition for IgG4-RD: a prospective single-arm clinical trial of telitacicept
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313947/ https://www.ncbi.nlm.nih.gov/pubmed/36657954 http://dx.doi.org/10.1136/ard-2022-223529 |
_version_ | 1785067215299543040 |
---|---|
author | Cai, Shaozhe Hu, Ziwei Chen, Yu Chen, Yuxue Ming, Bingxia Gao, Rongfen Li, Zhen Ye, Cong Zhong, Jixin Dong, Lingli |
author_facet | Cai, Shaozhe Hu, Ziwei Chen, Yu Chen, Yuxue Ming, Bingxia Gao, Rongfen Li, Zhen Ye, Cong Zhong, Jixin Dong, Lingli |
author_sort | Cai, Shaozhe |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10313947 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-103139472023-07-02 BLyS/APRIL dual inhibition for IgG4-RD: a prospective single-arm clinical trial of telitacicept Cai, Shaozhe Hu, Ziwei Chen, Yu Chen, Yuxue Ming, Bingxia Gao, Rongfen Li, Zhen Ye, Cong Zhong, Jixin Dong, Lingli Ann Rheum Dis Letter BMJ Publishing Group 2023-06 2023-01-19 /pmc/articles/PMC10313947/ /pubmed/36657954 http://dx.doi.org/10.1136/ard-2022-223529 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Letter Cai, Shaozhe Hu, Ziwei Chen, Yu Chen, Yuxue Ming, Bingxia Gao, Rongfen Li, Zhen Ye, Cong Zhong, Jixin Dong, Lingli BLyS/APRIL dual inhibition for IgG4-RD: a prospective single-arm clinical trial of telitacicept |
title | BLyS/APRIL dual inhibition for IgG4-RD: a prospective single-arm clinical trial of telitacicept |
title_full | BLyS/APRIL dual inhibition for IgG4-RD: a prospective single-arm clinical trial of telitacicept |
title_fullStr | BLyS/APRIL dual inhibition for IgG4-RD: a prospective single-arm clinical trial of telitacicept |
title_full_unstemmed | BLyS/APRIL dual inhibition for IgG4-RD: a prospective single-arm clinical trial of telitacicept |
title_short | BLyS/APRIL dual inhibition for IgG4-RD: a prospective single-arm clinical trial of telitacicept |
title_sort | blys/april dual inhibition for igg4-rd: a prospective single-arm clinical trial of telitacicept |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313947/ https://www.ncbi.nlm.nih.gov/pubmed/36657954 http://dx.doi.org/10.1136/ard-2022-223529 |
work_keys_str_mv | AT caishaozhe blysaprildualinhibitionforigg4rdaprospectivesinglearmclinicaltrialoftelitacicept AT huziwei blysaprildualinhibitionforigg4rdaprospectivesinglearmclinicaltrialoftelitacicept AT chenyu blysaprildualinhibitionforigg4rdaprospectivesinglearmclinicaltrialoftelitacicept AT chenyuxue blysaprildualinhibitionforigg4rdaprospectivesinglearmclinicaltrialoftelitacicept AT mingbingxia blysaprildualinhibitionforigg4rdaprospectivesinglearmclinicaltrialoftelitacicept AT gaorongfen blysaprildualinhibitionforigg4rdaprospectivesinglearmclinicaltrialoftelitacicept AT lizhen blysaprildualinhibitionforigg4rdaprospectivesinglearmclinicaltrialoftelitacicept AT yecong blysaprildualinhibitionforigg4rdaprospectivesinglearmclinicaltrialoftelitacicept AT zhongjixin blysaprildualinhibitionforigg4rdaprospectivesinglearmclinicaltrialoftelitacicept AT donglingli blysaprildualinhibitionforigg4rdaprospectivesinglearmclinicaltrialoftelitacicept |